FDAFebruary 26, 2021drug

Buprenorphine and Naloxone Sublingual Film 2mg/0.5mg, 30 pouches each containing 1 sublingual film, Distributed by: Alvogen, Inc. Pine Brook, NJ 07058 USA, NDC 47781-355-03

Official recall recorded by the U.S. Food & Drug Administration.

The hazard

Subpotent drug: Out of specification for assay of naloxone and buprenorphine (low)

What to do

FDA enforcement status: Terminated

Brands named

alvogen

Recall history

Other federal recalls tied to the same brand — a factual pattern, straight from the source data.

Own something like this?

AllClear screens your whole list against every CPSC, FDA, USDA and NHTSA recall — and tells you the day a new one names something you own.

Start free — 200 items, no card →